Dawn Orwick
About Dawn Orwick
Dawn Orwick serves as the Director of Finance Decision Support at Intermountain Health, where she oversees pricing strategies and cost management initiatives. She has extensive experience in finance and analytics within the healthcare sector, having held various roles at notable organizations such as Merck, SCL Health, and Teva Pharmaceuticals.
Current Role at Intermountain Health
Dawn Orwick serves as the Director of Finance Decision Support at Intermountain Health, a position she has held since 2024. In this role, she oversees the development of cost management dashboards and reports, focusing on Service Lines, Diagnosis-Related Groups (DRGs), and Physicians. She ensures continuous evaluation of cost data against key quality and satisfaction measures. Additionally, she coordinates with senior leadership to establish and implement the system-wide pricing strategy, ensuring consistency and accuracy during the annual pricing and revenue rate increase process.
Previous Experience in Healthcare Finance
Prior to her current role, Dawn Orwick worked at Intermountain Healthcare as a Senior Financial Analyst from 2021 to 2022. She also held positions at SCL Health, where she served as a Data Coordinator for Oncology and Cardiovascular Service Lines from 2018 to 2022, and as an Oncology & Cardiovascular Service Line Data Analyst from 2016 to 2018. Her experience in these roles contributed to her expertise in healthcare finance and data analysis.
Educational Background
Dawn Orwick earned her Bachelor’s degree in Biology from Albright College, where she studied from 1999 to 2003. She furthered her education by obtaining an MBA in Biotechnology and Health Industry Management from Penn State Great Valley, completing her studies from 2008 to 2010. This educational background provides her with a strong foundation in both biological sciences and business management within the healthcare sector.
Career History in Biopharmaceuticals
Dawn Orwick has extensive experience in the biopharmaceutical industry. She worked at Merck & Co., Inc. as a Staff Biologist from 2004 to 2006. Following that, she held positions at sanofi-aventis as Scientist I from 2006 to 2009, and at Cephalon as an Analyst in Government Contracts from 2010 to 2012. Additionally, she worked at Teva Pharmaceuticals in various roles related to Government Contracts from 2012 to 2013. These positions have equipped her with a diverse skill set in both scientific and financial analysis.
Collaboration and Training Initiatives
In her current role at Intermountain Health, Dawn Orwick collaborates with revenue cycle, operations, and managed care teams to manage the process for establishing competitive and standard prices for new charge codes. She also oversees the development and implementation of pricing training for finance and other staff, ensuring that the team is well-equipped to handle pricing strategies and data management effectively.